Cardio-renal syndrome type 1: epidemiology, pathophysiology, and treatment

Yousif Ismail1, Zaid Kasmikha, Henry L Green

  • 1Department of Medicine, Cardiology Section, Providence Hospital and Medical Center, Southfield, MI, USA.

Seminars in Nephrology
|February 28, 2012
PubMed

Insights

Acute kidney injury complicates one third of heart failure admissions, increasing hospital stay and readmission risk. Understanding cardio-renal syndrome interactions is key to managing this complex condition.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Acute kidney injury (AKI) complicates approximately one third of heart failure (HF) admissions.
  • AKI significantly increases hospital length of stay and rehospitalization rates.
  • Cardio-Renal Syndrome Type 1 (CRS 1) involves cardiac decompensation leading to renal failure, often associated with acute coronary syndromes and acute decompensated HF.

Purpose of the Study:

  • To explore the complex pathophysiology of renal dysfunction in the context of heart failure.
  • To highlight the intricate interactions between cardiac and renal systems in CRS 1.
  • To emphasize the importance of understanding these interactions for disease management.

Main Methods:

  • Review of existing literature on cardio-renal interactions.
  • Analysis of contributing factors to renal dysfunction in heart failure.
  • Discussion of the interplay between cardiovascular and renal systems.

Main Results:

  • Reduced cardiac output, renal congestion, and increased intra-abdominal pressure are key contributors to renal dysfunction.
  • Complex feedback loops involving the heart, kidneys, renin-angiotensin system, sympathetic nervous system, immune system, and vasculature are implicated.
  • Imbalances in these systems precipitate deterioration in both cardiac and renal function.

Conclusions:

  • Understanding the multifaceted pathophysiology of cardio-renal interactions is crucial.
  • This knowledge is essential for assessing disease burden, natural history, risk factors, and mortality.
  • Appreciation of these complex interactions informs therapeutic strategies for managing cardio-renal syndrome.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...